“Drying of Opzelura® (Ruxolitinib) Cream 1.5%: Implications for Clinical and Real-World Use”. SKIN The Journal of Cutaneous Medicine 8, no. 6 (November 18, 2024): s454. Accessed May 26, 2026. https://skin.dermsquared.com/skin/article/view/3063.